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Introduction
Calcifications are present almost solely in relation to atheroscle-
rosis in the coronary vessels except for individuals with chronic kid-
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Background and Objectives: Non-calcified plaque (NCP) identified by coronary CT angiography (CCTA) has been reported in up to 10% of 
individuals with coronary artery calcium score (CACS) of zero. However, clinical risk factors and the prognostic value of NCP in asymptom-
atic subjects with CACS of zero are unknown.
Subjects and Methods: The study population consisted of consecutive asymptomatic subjects (48±8 years, 57% men) who underwent 
CCTA from December 2005 to January 2008 as part of a general health evaluation.
Results: Among 4491 of overall asymptomatic individuals with CACS of zero, 313 subjects (7%) had NCP: 279 patients (6%) with non-
obstructive and 34 (1%) with obstructive. In multivariable analyses, age, male gender, diabetes, hypertension, and dyslipidemia were sig-
nificantly associated with presence of NCP (all p<0.05). During the median follow-up duration of 22 months (interquartile percentile: 18 to 
28 months) of subjects with NCP (n=313) and age, gender, and CCTA date matched individuals without NCP (n=313), there was no clinical 
event including all-cause death nor composite outcome of cardiac death, myocardial infarct, unstable angina requiring hospitalization, and 
revascularization after 90 days from index CCTA in both groups.
Conclusion: In the largest series of asymptomatic individuals with CACS of zero undergoing CCTA, age, male gender, diabetes, hyperten-
sion, and dyslipidemia were independently associated with NCP. However, a future risk of exclusive NCP in asymptomatic subjects with 
CACS of zero was negligible. (Korean Circ J 2013;43:154-160)
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ney disease.1) Therefore, coronary artery calcium score (CACS) has 
been used as a useful surrogate marker for coronary atherosclerosis 
burden. Furthermore, CACS provides prognostic information in as-
ymptomatic population.2-5) From these data, the use of CACS for 
risk stratification in asymptomatic population is advocated by pro-
fessional guidelines.6-8)
Coronary computed tomographic angiography (CCTA) has been 
introduced as a noninvasive imaging modality to directly assess the 
degree of coronary artery stenosis.9)10) The outstanding diagnostic 
accuracy of CCTA has been demonstrated by prospective multicen-
ter studies using coronary angiography (CA) as the reference stan-
dard.11)12) Widespread use of CCTA revealed a non-negligible preval-
ence of non-calcified plaque (NCP) in subjects with CACS of zero, 
who have very low probability of future cardiac adverse events.13-15) 
In symptomatic patients, NCPs are predictive of myocardial hypo-
perfusion and future coronary events.16-18) However, the clinical pre-
dictors and the prognosis of NCP in asymptomatic subjects with zero 
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CACS have not been fully evaluated.19)
Therefore, we evaluated the association of standard risk factors 
with NCP, and the prognosis of NCP in middle aged asymptomatic 
subjects with CACS of zero using CCTA. 
Subjects and Methods
Study population and design 
Between December 2005 and January 2008, we enrolled 5632 
consecutive subjects who underwent CCTA using 64-slice multi-de-
tector row computed tomography (MDCT) at Seoul National Uni-
versity Bundang Hospital (SNUBH). We included asymptomatic in-
dividuals who had CCTA as part of general health evaluation in a he-
alth promotion center. We excluded subjects as follows: 1) insuf-
ficient medical records or inadequate imaging for analyses (n=24); 
2) age less than 35 or more than 75 years (n=195); 3) subjects who 
had CACS >0 (n=922) for current analyses. As a result, 4491 middle-
aged individuals with CACS of zero were finally enrolled. The study 
protocol was approved by the Institutional Review Board and all pa-
tients provided written informed consent.
 
Imaging data acquisition and analyses
Data acquisition and image post-processing for CCTA and CACS 
were done in accordance with the Society of Cardiovascular Com-
puted Tomography guidelines,20) and detailed methods were de-
scribed in previous manuscript.21)
Coronary artery calcium scores were measured using the scoring 
system previously suggested by Agatston et al.22) The CCTA was 
performed on a 64-slice MDCT scanner (Brilliance 64, Philips Medi-
cal Systems, Best, The Netherlands). Beta blockade with intravenous 
esmolol, 10 to 30 mg (Jeil Pharm. Co., Ltd., Seoul, Korea) was used 
to achieve a heart-rate of <70 beats/minute. Eighty milliliter of in-
travenous contrast (Iomeron 400, Bracco, Milan, Italy) at a rate of 5 
mL/sec followed by 50 mL saline chaser were injected intravenously. 
A scanning protocol was as follows: 64×0.625 mm section colli-
mation, 420-ms rotation time, 120-kV tube voltage, 800-mA tube 
current. All scans were performed with electrocardiogram-gated dose 
modulation. The mean radiation exposure of CCTA was 13.21±0.82 
mSv (13.21± 0.83 for male and 13.33±0.79 for female).
Plaque assessment was independently performed by 2 experienc-
ed radiologists (Sang Il Choi, years of experience after board certific-
ation: 8 years; Eun Ju Jeon, years of experience after board certific-
ation: 6 years). Coronary atherosclerosis was defined as any tissue 
structures >1 mm2 that existed either within the coronary artery lu-
men or adjacent to the coronary artery lumen, which could be cl-
early discriminated from surrounding pericardial tissue or the vessel 
lumen itself. Each lesion was identified with a multiplanar reconst-
ruction technique and maximum intensity projection of short-axis, 
2-chamber, and 4-chamber views. Each identified lesion was exam-
ined using maximum-intensity-projection and multi-planar recon-
struction techniques along multiple longitudinal axes and in the tr-
ansverse plane. We analyzed plaque characteristics on a per-seg-
ment basis according to a 16-segment coronary artery tree model 
(left main; proximal, mid and distal left anterior descending artery 
(LAD); first and second diagonal branches of the LAD; proximal and 
distal left circumflex artery; first and second obtuse marginal bran-
ches of the left circumflex artery; proximal, mid and distal right co-
ronary artery; posterior descending artery; and left and right pos-
terolateral branch).20)23) 
Coronary artery stenosis was defined as presence of any plaque. 
Obstructive stenosis was defined when coronary artery segments 
exhibited plaque a luminal diameter stenosis ≥50%, and non-ob-
structive stenosis was defined when coronary artery segments ex-
hibited plaque with a luminal diameter stenosis <50%. An individu-
al with NCP was defined as presence of coronary stenosis, but CACS 
of 0.
Risk factor assessment and stratification
The baseline risk factors of coronary atherosclerosis were con-
sidered confounding variables, as previously described.22) Basic de-
mographic data for asymptomatic subjects was acquired from a 
database maintained by the SNUBH health promotion center. Medi-
cal history of hypertension, diabetes mellitus, cardiovascular disease, 
angina, current medication profile, and smoking status were syste-
matically acquired. Height, body weight, and blood pressure were 
measured during their visit. Total cholesterol, triglyceride, high den-
sity lipoprotein-cholesterol (HDL-C), low density lipoprotein-chole-
sterol (LDL-C), fasting plasma glucose, glycated hemoglobin, blood 
urea nitrogen (BUN), and creatinine level were measured after at 
least a 12 hours fasting period on the same day of the study. Hyper-
tension was defined as a self-reported history of hypertension and/ 
or use of anti-hypertensive medication, or a blood pressure ≥140/ 
90 mm Hg. Diabetes mellitus was defined as a self-reported history 
of diabetes and/or receiving anti-diabetic treatment, or a fasting pla-
sma glucose ≥126 mg/dL. We categorized all subjects into three risk 
groups according to the revised National Cholesterol Education Prog-
ram (NCEP) guidelines: high-risk {history of coronary heart disease 
(CHD), CHD risk equivalents, or 10-year risk >20%}, moderate-risk 
(more than 2 risk factors and 10-year risk >20%), and low-risk gr-
oup (0 to 1 risk factor).24)
Patient follow-up
To assess prognosis of individuals with NCP, we selected age, gen-
der, CCTA date (±7 days)-matched controls among the subjects with-
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out NCP. If there are more subjects who meet the matching criteria, 
the matched-control subject was randomly selected among the qu-
alified subjects. Matching was performed by the Medical Research 
Collaborating Center at Seoul National University Hospital.
After the matching group was selected, follow-up for events was 
performed by a dedicated physician and/or research nurse blinded 
to the CCTA results. Ascertainment of events was performed by te-
lephone contact and/or review of medical records. The primary end-
point was all-cause death and the secondary outcome was the 
composite outcome of cardiac death, non-fatal myocardial infarc-
tion (MI), unstable angina (UA) requiring hospitalization, and re-
vascularization after 90 days of index CCTA. We only considered 
revascularizations more than 90 days after CCTA as outcome events 
to exclude downstream revascularization procedures related to in-
dex CCTA.25-27) 
Statistical analysis 
Continuous variables are expressed as means±1 standard devia-
tion, whereas categorical variables are presented as frequencies. Dif-
ferences between continuous variables were analyzed by Student’s 
unpaired t-test and those between categorical variables by the chi-
square test or Fisher’s exact test, as appropriate. In addition, to com-
pare differences of continuous variables and categorical variables 
between matched controls and patients, paired t-test and McNe-
mar test were performed.
Univariable and multivariable binary logistic regression analyses 
were performed to determine association of standard risk factors 
and NCP. In the analysis, we selected standard risk factors as follows: 
age, gender, current cigarette smoking status, body mass index (BMI), 
disease status of hypertension, diabetes mellitus. The covariates-ad-
justed odds ratios (OR) and their 95% confidence intervals (CI) were 
derived in multiple logistic regression models. Null hypotheses of 
no difference were rejected if p were less than 0.05 or, equivalently, 
if the 95% CIs of OR estimates excluded 1. All analyses were per-
formed with Statistical Package for the Social Sciences (SPSS) 13.0 
statistical package (SPSS Inc., Chicago, IL, USA).
 
Results
Baseline characteristics by plaque characteristics
The distribution of individuals according to plaque severity was 
described in Table 1. Among 4491 of overall individuals without CAC, 
313 subjects (7%) had coronary plaques: 279 patients (6%) with 
non-obstructive plaque and 34 (1%) with obstructive plaque. Am-
ong the subjects with obstructive plaque, 30 subjects (88%) were 
1- vessel diseases (VD), 1 subject (3%) was 2-VD, and 3 subjects (9%) 
were left main disease. There is no subject with obstructive 3-VD. 
The main clinical characteristics of study subjects without CAC ac-
cording to plaque characteristics were listed in Table 2. Overall, the 
study population consisted of 4491 individuals without CAC: 57% 
were male with a mean age was 48±8 years. Subjects with NCP 
were generally older, male, and with a higher prevalence of hyperten-
sion, diabetes, and dyslipidemia (all p<0.001). Subjects with NCP also 
had higher BMI, triglyceride, LDL-C, BUN, creatinine level, but lower 
HDL-C level compared to those without NCP. Furthermore, individ-
uals with NCP had a higher NCEP-ATP III risk (p<0.001): only 55% 
of individuals with NCP were categorized as low risk according to 
NCEP risk stratification category while 73% of individuals without 
NCP were categorized as low risk.
Association of clinical risk factors with prevalence 
of non-calcified plaque
In univariable binary logistic regression analyses, age, male gender, 
hypertension, diabetes, dyslipidemia, current smoking, and BMI were 
associated with presence of NCP (Table 3). In multivariable logistic 
regression analyses, age (OR 1.04, 95% CI 1.02-1.05, p<0.001), male 
gender (OR 3.24, 95% CI 2.38-4.41, p<0.001), hypertension (OR 1.35, 
95% CI 1.00-1.82, p=0.049), diabetes (OR 1.67, 95% CI 1.13-2.46, p= 
0.010), and dyslipidemia (OR 1.67, 95% CI 1.05-2.66, p=0.032) were 
independent risk factors for NCP in a model including age, gender, hy-
pertension, diabetes, dyslipidemia, current smoking, and BMI. 
Midterm outcome of individuals with non-calcified plaque
During the median follow-up duration of 22 months (25th to 
75th percentile: 18 to 28 months), there is no all-cause death in 
subjects with NCP group (n=313) nor in age, sex, and CCTA date ma-
tched control subjects (n=313) (Table 4). For composite outcome of 
cardiac death, non-fatal MI, UA requiring hospitalization, and revas-
cularization after 90 days from index CCTA, no event was reported in 
either group. All revascularization procedures (n=4) during follow-
up period were performed within 90 days of the index CCTA. 
Discussion
In a large series of individuals with CACS of zero undergoing CC-
Table 1. Distribution of subjects by plaque severity and symptom status 
in subjects without coronary artery calcium
Plaque characteristics (number of patients) 4491
No plaque (%) 4178 (93)
Presence of plaque (%) 313 (7)
Non-obstructive (<50%) 279 (6)
Obstructive (≥50%) 34 (1)
Data are expressed as number (%)
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TA, age, male gender, diabetes, hypertension, and dyslipidemia were 
independent predictors of NCP. We also observed a negligible future 
cardiac risk of exclusive NCP in middle aged asymptomatic sub-
jects.
Prevalence and risk factors of non-calcified plaque
The prevalence of any NCP (>0%) was 6.2% and obstructive NCP 
(≥50%) was 0.7% in subjects with zero CACS. The prevalence of 
NCP in subjects with zero calcium in previous studies was varied. 
Cheng et al.28) showed prevalence of detectable NCP was 6.5% (27/ 
416) (6.0%, non-obstructive; 0.5%, obstructive) in low to intermedi-
ate risk patients (80% of patients had chest pain or dyspnea). Akram 
et al.13) reported that 8.2% (4/49) had obstructive NCP in symptom-
atic patients, but no asymptomatic subjects (0/76) had obstructive 
NCP. However, Ergün et al.14) reported higher prevalence of NCP com-
pared to the current study: 17% (54/320) had NCP and 3% (10/320) 
had obstructive NCP in asymptomatic subjects. Rubenstein et al.15) 
also found 14% (25/125) of symptomatic patients with zero calcium 
had NCP. The discrepancy of the prevalence of NCP might originate 
from the difference in pretest probability of coronary artery disease 
Table 2. Baseline characteristics by the presence of non-calcified plaque in asymptomatic individuals with coronary artery calcium score of zero
Overall NCP (-) NCP (+) p 
No. of patients 4491 4178 313
Age 48±8 48±8 50±9 <0.001
Male gender (%) 2564 (57) 2314 (55) 250 (80) <0.001
Hypertension (%) 676 (15) 600 (14) 76 (24) <0.001
Diabetes mellitus (%) 254 (6) 218 (5) 36 (12) <0.001
Dyslipidemia (%) 176 (4) 151 (4) 25 (8) <0.001
Current smoking (%) 1165 (27) 1062 (26) 103 (33) 0.008
BMI 23.9±3.0 23.8±3.0 24.4±2.7 0.001
Total Cholesterol 202±35 201±34 208±36 0.001
Triglyceride 128±82 126±79 154±113 <0.001
HDL-C 56±13 56±14 52±12 <0.001
LDL-C 107±26 107±26 112±26 <0.001
BUN 12.7±3.3 12.7±3.3 13.3±3.9 0.005
Creatinine 1.0±0.2 1.0±0.2 1.1±0.2 <0.001
CRP 0.1±0.6 0.1±0.6 0.2±0.5 0.221
NCEP-ATP III Risk category (%) <0.001
Low risk 3213 (71) 3040 (73) 173 (55)
Intermediate risk 1024 (23) 920 (22) 104 (33)
High risk 254 (6) 218 (5) 36 (12)
Data are expressed as mean±standard deviation or number (%). NCP: non-calcified plaque, BMI: body mass index, BUN: blood urea nitrogen, CRP: C-reac-
tive protein, HDL: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, NCEP-ATP III: National Cholesterol Education Program 
Adult Treatment Panel III
Table 3. Univariable and multivariable logistic regression analyses for risk of non-calcified plaque in an asymptomatic population with a coronary artery 
calcium score of zero
Univariable analyses Multivariable analyses*
OR (95% CI) p OR (95% CI) p
Age (years) 1.03 (1.02-1.05) <0.001 1.04 (1.02-1.05) <0.001
Male gender 3.20 (2.41-4.24) <0.001 3.24 (2.38-4.41) <0.001
Hypertension 1.91 (1.46-2.51) <0.001 1.35 (1.00-1.82) 0.049
Diabetes 2.36 (1.63-3.43) <0.001 1.67 (1.13-2.46) 0.010
Dyslipidemia 2.32 (1.49-3.59) <0.001 1.67 (1.05-2.66) 0.032
Current smoking 1.37 (1.07-1.75) 0.013 1.06 (0.81-1.39) 0.674
Body mass index 1.06 (1.02-1.10) 0.002 0.99 (0.95-1.04) 0.714
*Adjusted for diabetes mellitus, hypertension, smoking, dyslipidemia, male gender, and age. CI: confidence interval, OR: odds ratio
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(CAD) and ethnicity of study population. We believe that the accu-
racy study of CCTA using ICA as a standard test by Cademartiri et al. 
provided a good reference of the prevalence of NCP. The prevalence 
of obstructive NCP in zero calcium demonstrated at CAG was 1.4% 
(1/71) in asymptomatic subjects which was similar to current study 
(0.7%).
To our knowledge, there is no study that evaluated risk factors 
for NCP in an asymptomatic population with zero CACS. Multivari-
able logistic regression analyses identified old age, male gender, 
diabetes, hypertension, and dyslipidemia as independent risk fac-
tors for NCP in asymptomatic population with zero calcium in cur-
rent study. Therefore, it should be noted that individuals with old age, 
male gender, diabetes, hypertension, and dyslipidemia have a higher 
risk of NCP although they have zero CACS in clinical practice.
Prognosis of non-calcified plaque in individuals with zero 
coronary artery calcium score 
In patients with suspected CAD van Werkhoven et al.18) found that 
NCP was independent predictor with an incremental prognostic val-
ue to CACS. Motoyama et al.17) also showed that low-attenuation 
plaque on CCTA was a risk factor for future acute coronary syndr-
ome in patients with suspected or known CAD. However, there is lack 
of study that analyzed the prognosis of NCP in asymptomatic po-
pulation with zero CACS. 
The current study clearly demonstrated a negligible risk of exclu-
sive NCP in subjects with zero CACS. During the median follow-up 
duration of 22 months (interquartile percentile: 18 to 28 months), 
there was no cardiac event in the NCP group nor even in the control 
group without NCP. This indicates that a CACS of zero successfully 
discriminates the future risk of cardiac events in asymptomatic pop-
ulation. Recently, the results from international multicenter CCTA 
registry showed that CCTA barely added prognostic value over CACS 
in population without chest pain syndrome.29) The results of the cur-
rent study, which showed fairly good prognosis in an asymptomatic 
population with zero CACS, would be able to explain why CCTA 
failed to show significant added prognostic value over CACS.
Another important reason why CCTA failed to stratify future risk 
of NCP in asymptomatic subjects with CACS of zero is that the pre-
test probability of CAD in the current study population is low. Al-
though 4491 subjects with no CAC were included in current analy-
ses, the subjects with NCP were only 7% (313 subjects). Moreover, a 
follow-up duration of 22 months might not be enough to discrim-
inate future risk of NCP in the current asymptomatic population. 
Therefore, future studies with longer follow-up and a larger popu-
lation might prove the prognostic value of NCP identified by CCTA 
for risk prediction in this low-risk population with zero CACS. 
However, CCTA has potential hazards including radiation expo-
sure and intravenous use of contrast agent. Further, additional costs 
related to CCTA must be considered. Therefore, for present, the ap-
plication of CCTA to detect NCP for risk stratification purpose in an 
asymptomatic population with CACS of zero should not be justified. 
Table 4. Midterm outcome of subjects with non-calcified plaque and age, sex, and CCTA date matched subjects without non-calcified plaque
Subjects with NCP (cases) Subjects without NCP (controls)* p
Number of patients 313 313 NA
Baseline characteristics
Age 50±9 50±9 0.757
Male gender (%) 250 (80) 250 (80) 1.000
Current smoking (%) 103 (33) 91 (30) 0.436
Diabetes (%) 36 (12) 19 (6) 0.023
Hypertension (%) 76 (24) 61 (20) 0.176
Body mass index 24.5±2.7 24.4±2.7 0.567
Mean follow up (days) 686±185 681±184 0.757
Follow up rate (%) 93.9 91.0 0.117
Midterm outcomes (%)
All-cause death† 0 (0) 0 (0) NA
Composite outcome‡ 0 (0) 0 (0) NA
Revascularization procedures within 90 days from CCTA§ 4 (1) 0 (0) 0.067
Data are expressed as number (percentage), or mean±standard deviation. *Age, sex, and CCTA date matched subjects without non-calcified plaque, †Causes 
of 2 non-cardiac deaths: cancer, ‡Cardiac death, unstable angina, non-fatal myocardial infarction, and revascularization procedures including percutane-
ous coronary intervention and coronary artery bypass surgery after 90 days from index coronary computed tomographic angiography, §Revascularization 
procedures including percutaneous coronary intervention and coronary artery bypass surgery. CABG: coronary artery bypass graft, CCTA: coronary com-
puted tomographic angiography, n: number, NA: not applicable, NCP: non-calcified plaque
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Study limitation
This study is not without limitations. We retrospectively looked 
at a population who underwent CCTA in a health promotion center 
on a self-referral basis. Therefore, selection bias could influence the 
results. In addition, the influence of post-test medical treatments, 
coronary intervention within 90 days, or risk factor control was not 
considered. Further, we used a 90 day window period to exclude 
downstream revascularization procedures related to CCTA. Thus, a 
revascularization procedure which was performed within 90 days 
from CCTA, but not a downstream procedure might be excluded 
from the clinical outcome. Moreover, the topographic distribution of 
coronary plaques, and various plaque assessment approaches in-
cluding area stenosis, minimal lumen diameter, and minimal lumen 
area were not included in current analyses.
Conclusion
In the largest series of asymptomatic subjects with CACS of zero 
undergoing CCTA, we find a negligible risk of exclusively NCP. Our 
findings suggest that the application of CCTA to detect NCP for risk 
stratification purpose in asymptomatic population with CACS of 
zero is not justified. 
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